1-3 of 3
breast carcinoma, lobular, invasive
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML

Bérengère Salomé, Alejandra Gomez-Cadena, Romain Loyon, Madeleine Suffiotti, Valentina Salvestrini, Tania Wyss, Giulia Vanoni, Dan Fu Ruan, Marianna Rossi, Alessandra Tozzo, Paolo Tentorio, Elena Bruni, Carsten Riether, Eva-Maria Jacobsen, Peter Jandus, Curdin Conrad, Manfred Hoenig, Ansgar Schulz, Katarzyna Michaud, Matteo Giovanni Della Porta, Silvia Salvatore, Ping-Chih Ho, David Gfeller, Adrian Ochsenbein, Domenico Mavilio, Antonio Curti, Emanuela Marcenaro, Alexander Steinle, Amir Horowitz, Pedro Romero, Sara Trabanelli, Camilla Jandus
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3674–3687.
https://doi.org/10.1182/bloodadvances.2018030478
Published: 2019
Includes: Supplemental data
Journal Articles

Human ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease

Mette D. Hazenberg, Nienke J. E. Haverkate, Yannouck F. van Lier, Hergen Spits, Lisette Krabbendam, Willem A. Bemelman, Christianne J. Buskens, Bianca Blom, Medya M. Shikhagaie
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3650–3660.
https://doi.org/10.1182/bloodadvances.2019000176
Published: 2019
Includes: Supplemental data
Journal Articles

A functional DC cross talk promotes human ILC homeostasis in humanized mice

Silvia Lopez-Lastra, Guillemette Masse-Ranson, Oriane Fiquet, Sylvie Darche, Nicolas Serafini, Yan Li, Mathilde Dusséaux, Helene Strick-Marchand, James P. Di Santo
Journal: Blood Advances
Blood Adv (2017) 1 (10): 601–614.
https://doi.org/10.1182/bloodadvances.2017004358
Published: 2017
Includes: Supplemental data